Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Dabigatran etexilate 75 mg hard capsules

Active Ingredient:
dabigatran etexilate mesilate
Company:  
Biocon Pharma UK Limited See contact details
ATC code: 
B01AE07
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Dabigatran etexilate - Patient Alert Card

Dabigatran etexilate Information for Patients / Caregivers of paediatric patients

{pdf_link}

Dabigatran etexilate-Prescriber Guide (deep vein thrombosis & pulmonary embolism)

{healthcare_pro_orange} For Healthcare Professionals

Dabigatran etexilate-Prescriber Guide (deep vein thrombosis & pulmonary embolism)

{pdf_link}

Dabigatran etexilate-Prescriber Guide (paediatric use)

{healthcare_pro_orange} For Healthcare Professionals

Dabigatran etexilate-Prescriber Guide (paediatric use)

{pdf_link}

Dabigatran etexilate-Prescriber Guide (prevention of venous thromboembolic events)

{healthcare_pro_orange} For Healthcare Professionals

Dabigatran etexilate-Prescriber Guide (prevention of venous thromboembolic events)

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Biocon Pharma UK Limited
Company image
Address
16 Great Queen Street, Covent Garden, London, WC2B 5AH, UK
WWW
https://www.biocon.com
Telephone
+44 7538 839 251
Medical Information Direct Line
00 8000 825 0866
Medical Information e-mail
[email protected]
Customer Care direct line
00 8000 825 0866
Medical Information Fax
+91 80 67755 900